Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1958 1
1960 1
1963 1
1965 1
1966 1
1969 1
1970 1
1972 1
1973 1
1975 2
1976 1
1977 2
1978 1
1980 2
1986 4
1987 1
1988 1
1989 1
1990 1
1992 1
1993 1
1995 1
2001 3
2002 1
2003 2
2004 1
2005 3
2006 1
2007 5
2008 2
2009 1
2012 3
2013 3
2014 2
2015 4
2016 2
2017 1
2018 1
2020 4
2021 9
2022 8
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Turner NC, Swift C, Jenkins B, Kilburn L, Coakley M, Beaney M, Fox L, Goddard K, Garcia-Murillas I, Proszek P, Hall P, Harper-Wynne C, Hickish T, Kernaghan S, Macpherson IR, Okines AFC, Palmieri C, Perry S, Randle K, Snowdon C, Stobart H, Wardley AM, Wheatley D, Waters S, Winter MC, Hubank M, Allen SD, Bliss JM; c-TRAK TN investigators. Turner NC, et al. Ann Oncol. 2023 Feb;34(2):200-211. doi: 10.1016/j.annonc.2022.11.005. Epub 2022 Nov 22. Ann Oncol. 2023. PMID: 36423745 Free article. Clinical Trial.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
Do Not Give Up.
Roux RL, Hall MR, Rustin GJS, Zweifel M. Roux RL, et al. Int J Gynecol Cancer. 2017 Jul;27(6):1060-1062. doi: 10.1097/IGC.0000000000000584. Int J Gynecol Cancer. 2017. PMID: 26575275 Free PMC article. No abstract available.
Performance of parotidectomy in nonspecialist centers.
Umapathy N, Holmes R, Basavaraj S, Roux R, Cable HR. Umapathy N, et al. Among authors: roux r. Arch Otolaryngol Head Neck Surg. 2003 Sep;129(9):925-8; discussion 928. doi: 10.1001/archotol.129.9.925. Arch Otolaryngol Head Neck Surg. 2003. PMID: 12975262 Review.
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Starkey T, Ionescu MC, Tilby M, Little M, Burke E, Fittall MW, Khan S, Liu JKH, Platt JR, Mew R, Tripathy AR, Watts I, Williams ST, Appanna N, Al-Hajji Y, Barnard M, Benny L, Burnett A, Bytyci J, Cattell EL, Cheng V, Clark JJ, Eastlake L, Gerrand K, Ghafoor Q, Grumett S, Harper-Wynne C, Kahn R, Lee AJX, Lomas O, Lydon A, Mckenzie H; NCRI Consumer Forum; Panneerselvam H, Pascoe JS, Patel G, Patel V, Potter VA, Randle A, Rigg AS, Robinson TM, Roylance R, Roques TW, Rozmanowski S, Roux RL, Shah K, Sheehan R, Sintler M, Swarup S, Taylor H, Tillett T, Tuthill M, Williams S, Ying Y, Beggs A, Iveson T, Lee SM, Middleton G, Middleton M, Protheroe A, Fowler T, Johnson P, Lee LYW. Starkey T, et al. Among authors: roux rl. Sci Rep. 2023 Jul 25;13(1):11327. doi: 10.1038/s41598-023-36990-9. Sci Rep. 2023. PMID: 37491478 Free PMC article.
Particle assemblies: toward new tools for regenerative medicine.
Roux R, Ladavière C, Montembault A, Delair T. Roux R, et al. Mater Sci Eng C Mater Biol Appl. 2013 Apr 1;33(3):997-1007. doi: 10.1016/j.msec.2012.12.002. Epub 2012 Dec 11. Mater Sci Eng C Mater Biol Appl. 2013. PMID: 23827536 Review.
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
Nicum S, McGregor N, Austin R, Collins L, Dutton S, McNeish I, Glasspool R, Hall M, Roux R, Michael A, Clamp A, Jayson G, Kristeleit R, Banerjee S, Mansouri A. Nicum S, et al. Among authors: roux r. Br J Cancer. 2024 Apr;130(6):941-950. doi: 10.1038/s41416-023-02567-6. Epub 2024 Jan 20. Br J Cancer. 2024. PMID: 38245661 Free PMC article. Clinical Trial.
92 results